Latest News

FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap
FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap

April 3rd 2025

The company stated that the FDA noted at least one additional adequate and well controlled study to demonstrate a positive effect on the treatment of ocular symptoms of dry eye should be conducted.

A novel radiosurgical platform to treat a case of uveal melanoma
A novel radiosurgical platform to treat a case of uveal melanoma

April 3rd 2025

Ocular effects of methylphenidate in children and adolescents with ADHD
Ocular effects of methylphenidate in children and adolescents with ADHD

April 2nd 2025

Ocular involvement in multiple myeloma
Ocular involvement in multiple myeloma

April 1st 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.